Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Annals of Nuclear Medicine|February 25, 2026
[11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myelomaElgin Ozkan, Burak Demir, Guldane Cengiz Seval, et al.
Biomedicines|September 28, 2023
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate CancerRie von Eyben, Manuela Andrea Hoffmann, Cigdem Soydal, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the LiteratureYusuf Sukru Caglar, Murat Buyuktepe, Emre Yagiz Sayaci, et al.
Journal of Ovarian Research|January 20, 2026
Additive value of whole abdomen FDG PET/MRI to standard whole body PET/CT for detection of peritoneal recurrence of ovarian cancerMuhammet Halil Baltacioglu, Cigdem Soydal, Mine Araz, et al.
Annals of Nuclear Medicine|August 29, 2024
Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheresBurak Demir, Cigdem Soydal, Nuriye Ozlem Kucuk, et al.
Nuclear Medicine Communications|January 11, 2023
Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective studyPinar Akkus Gunduz, Elgin Ozkan, Digdem Kuru Oz, et al.
Cancers|February 25, 2023
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
Cancers|November 11, 2022
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-AnalysisRie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann, et al.
International Journal of Molecular Sciences|December 2, 2020
Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-AnalysisFinn Edler von Eyben, Glenn Bauman, Rie von Eyben, et al.
Annals of Nuclear Medicine|April 23, 2025
Comparative voxel-based dosimetry with pre-treatment Tc-99m SPECT/CT and post-treatment Y-90 PET/MRI for radioembolization with Y-90 microspheresBurak Demir, Nuriye Ozlem Kucuk, Cigdem Soydal, et al.
Pageof 7